Immunological incompatibility as a basis for cancer curing and vaccination

Deliverables

Launch of the project visual identity logo and other grapic elements the project website and social media channels Twitter account and LinkedIn page

Communication materials

Communication materials will include the project flyer a short presentation video an official power point presentation of the project a rollup poster

First set of potentially useful monoclonal anti-HLA-A antibodies

Description of a first set of potentially useful monoclonal antiHLAA antibodies capable of reacting against the alloHLA antigens expressed on the surface of tumour cells

Synthesis and characterization of NPs

NPs will be prepared following solgel routes and fully characterized using different techniques including electron microscopy powder xray diffraction porosimetry etc

Report on establishment of optimal collection, processing, storing and analysis of biological materials from patients

A report explaining the establishment of optimal collection processing storing and analysis of biological materials from pancreatic cancer patients

Production of transfection grade plasmid DNA (pDNA) to be used in T3.4 (assessment of pDNA effect in target cells)

Required amounts of pDNA will be produced following standard internal procedures

Constitution of the different management committees

The following committees will be formally constituted1 Project Management and Steering Committee PMSC 2 Scientific and Technical Committee STC3 Innovation and Exploitation Committee IXC4 Ethics Management Committee EMC

Data Management Plan

The Data Management Plan will provide the protocols to be followed in the management and treatment of data

Publications

A minimal miR-142T-transgene design detargets expression from myeloid cells in the absence of a sponge effect

Author(s): Marta Parés, Aleix Angrill, Victor Pallaruelo-Santamaría, Cristina Fillat
Published in: 2025
Publisher: manuscript in preparation

Evaluation of the efficacy of a monoclonal antibody for the treatment of pancreatic cancer by complement-dependent cytotoxicity

Author(s): Ceballos-Francisco D., Ruiz Lorente I., Gimeno L., Martinez-Sanchez M.V., Parés Casellas M., Heidt S., Class F., Niemann M., Spierings E. Pallaruelo -Santamaria V., Fillat C, Minguela A
Published in: 2024
Publisher: 7th European Congress of Immunology

Development of lipid nanoparticles loaded with nucleic acids for reprogramming cancer cells and restore immune-mediated cell death

Author(s): Vicente Candela-Noguera, Javier Martínez-Latorre, Marta Parés, Alba García-Fernández, Elena Aznar, Cristina Fillat, Ramón Martínez-Máñez
Published in: 6th International Caparica Symposium on Nanoparticles/Nanomaterials and Applications 2024. Lisboa, 2024, ISBN 978-989-35197-2-1
Publisher: Printed by: PROTEOMASS Scientific Society

Development of lipid nanoparticles loaded with nucleic acids for reprogramming cancer cells and restore immune-mediated cell death

Author(s): Vicente Candela-Noguera, Javier Martínez-Latorre, Marta Parés, Alba García-Fernández, Elena Aznar, Cristina Fillat, Ramón Martínez-Máñez
Published in: XVI International Workshop on Sensors and Molecular Recognition. Valencia., 2023, ISBN 978-84-09-55991-6
Publisher: Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico

Anti-CD47 multifunctionalized lipid nanoparticles target pancreatic cancer cells and promote macrophage phagocytosis.

Author(s): Vicente Candela-Noguera, Marta Parés, Javier Martínez-Latorre, Alba García-Fernández, Elena Aznar, Victor Pallaruelo-Santamaría, Cristina Fillat, Ramón Martínez-Máñez
Published in: 2025
Publisher: (manuscript in preparation)

T-Cell Epitopes Shared Between Immunizing HLA and Donor HLA Associate With Graft Failure After Kidney Transplantation

Author(s): Emma T. M. Peereboom, Benedict M. Matern, Toshihide Tomosugi, Matthias Niemann, Julia Drylewicz, Irma Joosten, Wil A. Allebes, Arnold van der Meer, Luuk B. Hilbrands, Marije C. Baas, Franka E. van Reekum, Marianne C. Verhaar, Elena G. Kamburova, Marc A. J. Seelen, Jan Stephan Sanders, Bouke G. Hepkema, Annechien J. Lambeck, Laura B. Bungener, Caroline Roozendaal, Marcel G. J. Tilanus, Christien E.
Published in: Frontiers in Immunology, Issue 12, 2023, ISSN 1664-3224
Publisher: Frontiers in Inmunology
DOI: 10.3389/fimmu.2021.784040

Peptides Derived From Mismatched Paternal Human Leukocyte Antigen Predicted to Be Presented by HLA-DRB1, -DRB3/4/5, -DQ, and -DP Induce Child-Specific Antibodies in Pregnant Women

Author(s): Matthias Niemann, Benedict M. Matern, Eric Spierings, Stefan Schaub, Gideon Hönger
Published in: Frontiers in Immunology, Issue 12, 2021, ISSN 1664-3224
Publisher: Frontiers in Immunology
DOI: 10.3389/fimmu.2021.797360

A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.

Author(s): Jose Antonio Lopez Guerrero, Marcos Melián-Sosa, Zoraida Andreu Martínez, Raquel López-Reig, Antonio Fernández-Serra, Isidro Machado, Ricardo Yaya-Tur, María García-Flores, Marta Trallero-Anoro, Carmen Martínez-Lapiedra, Fernando Martínez de Juan, Marta Ramírez-Calvo, Tania Mazcuñan-Vitiello, Patricia Carretero-Hinojosa, Rafael Estevan
Published in: Journal of Clinical Oncology, Issue 42, 2024, Page(s) 681-681, ISSN 0732-183X
Publisher: American Society of Clinical Oncology
DOI: 10.1200/jco.2024.42.3_suppl.681

A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments

Author(s): Irene Pérez-Díez, Zoraida Andreu Marta R Hidalgo, Carla Perpiñá-Clérigues, Lucía Fantín, Antonio Fernandez-Serra, María de la Iglesia-Vaya, José A Lopez-Guerrero, Francisco García-García
Published in: Cancers (Basel), Issue 2023 May 24;15(11):2887, 2023, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers15112887

Deliverables

Publications

Share this page

Download